Xcout Intel
Maxion Therapeutics
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Subscribe to see Maxion Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Maxion Therapeutics at a glance
Maxion Therapeutics is a biotech company headquartered in United Kingdom, founded in 2020. Xcout tracks 12 named people at Maxion Therapeutics, including Arndt Schottelius (CEO).
Maxion Therapeutics leadership
- Arndt SchotteliusCEO
- Joel EdwardsCBO
- Stefan HärtleCDO
- John McCaffertyCo-founder and CTO
- Aneesh Karatt-VellattCo-founder and CSO
- Eva-Lotta AllanIndependent Chair
6 more named people on record for Maxion Therapeutics, with roles, board committees and tenure — see the full roster →
Maxion Therapeutics competitors
A few of Maxion Therapeutics's closest competitors — see the full list of competitors and alternatives →
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Mission Therapeutics is a drug discovery and development company recognized as a global leader in targeting deubiquitylating enzymes. Founded in 2011, the firm is based at the Babraham Research Campus in Cambridge, United Kingdom.
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Get Maxion Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Maxion Therapeutics in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access